Mark Craighead

Title: Mark Craighead: Innovator in Pharmaceutical Chemistry

Introduction

Mark Craighead is a notable inventor based in Manchester, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on redox derivatives of active pharmaceutical compounds.

Latest Patents

Mark Craighead holds a patent for "Substituted [1,2,4]triazolo[4,3-A]pyrazines for medicaments and pharmaceutical compositions." This invention relates to derivatives of known active pharmaceutical compounds. These derivatives are distinguished from the parent active compound by being redox derivatives. This means that one or more functional groups in the active compound have been converted to another group through reactions that represent a change of oxidation state. The compounds are generally referred to as redox derivatives. The derivatives may be related to the original parent active pharmaceutical compound through a single step transformation or via several synthetic steps, including one or more changes of oxidation state.

Career Highlights

Mark Craighead is associated with Redx Pharma Limited, where he has been instrumental in advancing pharmaceutical research and development. His work has contributed to the understanding and application of redox derivatives in medicinal chemistry.

Collaborations

Throughout his career, Mark has collaborated with notable colleagues, including Ronald Palin and Neil Murray. These collaborations have further enhanced the impact of his research in the pharmaceutical industry.

Conclusion

Mark Craighead's innovative contributions to pharmaceutical chemistry, particularly through his patent on redox derivatives, highlight his role as a significant inventor in the field. His work continues to influence the development of new medicaments and pharmaceutical compositions.